$2.59 Billion is the total value of Deep Track Capital, LP's 63 reported holdings in Q3 2023. The portfolio turnover from Q2 2023 to Q3 2023 was 43.6% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| INSM | Sell | INSMED INC | $151,500,000 | +10.5% | 6,000,000 | -7.7% | 5.85% | -7.9% |
| JAZZ | Sell | JAZZ PHARMACEUTICALS PLC | $147,308,545 | -4.9% | 1,138,045 | -9.0% | 5.69% | -20.7% |
| ITCI | Buy | INTRA-CELLULAR THERAPIES INC | $135,434,000 | +38.1% | 2,600,000 | +67.9% | 5.23% | +15.2% |
| IONS | IONIS PHARMACEUTICALS INC | $128,553,370 | +10.6% | 2,834,069 | 0.0% | 4.96% | -7.8% | |
| GH | Buy | GUARDANT HEALTH INC | $120,042,000 | +123.5% | 4,050,000 | +170.0% | 4.63% | +86.4% |
| IMVT | Sell | IMMUNOVANT INC | $107,413,492 | +4.4% | 2,797,955 | -48.4% | 4.15% | -12.9% |
| ALKS | Buy | ALKERMES PLC | $106,438,000 | +13.4% | 3,800,000 | +26.7% | 4.11% | -5.5% |
| DVAX | Buy | DYNAVAX TECHNOLOGIES CORP | $99,800,240 | +17.8% | 6,756,956 | +3.0% | 3.85% | -1.8% |
| Sell | STRUCTURE THERAPEUTICS INCsponsored ads | $96,554,300 | -12.2% | 1,915,000 | -27.6% | 3.73% | -26.8% | |
| PLRX | Buy | PLIANT THERAPEUTICS INC | $95,370,000 | +30.0% | 5,500,000 | +35.8% | 3.68% | +8.4% |
| SWTX | SPRINGWORKS THERAPEUTICS INC | $81,993,577 | -11.8% | 3,546,435 | 0.0% | 3.16% | -26.5% | |
| AXSM | Buy | AXSOME THERAPEUTICS INC | $79,726,668 | +188.8% | 1,140,745 | +196.9% | 3.08% | +140.8% |
| BCYC | Buy | BICYCLE THERAPEUTICS PLCsponsored ads | $70,124,266 | -2.5% | 3,490,506 | +23.8% | 2.71% | -18.7% |
| TVTX | TRAVERE THERAPEUTICS INC | $65,887,800 | -41.8% | 7,370,000 | 0.0% | 2.54% | -51.5% | |
| NTLA | Buy | INTELLIA THERAPEUTICS INC | $63,240,000 | +85.6% | 2,000,000 | +139.4% | 2.44% | +54.8% |
| EDIT | Buy | EDITAS MEDICINE INC | $55,395,093 | +94.9% | 7,101,935 | +105.6% | 2.14% | +62.5% |
| GERN | Buy | GERON CORP | $54,484,000 | -29.8% | 25,700,000 | +6.3% | 2.10% | -41.5% |
| VRNA | VERONA PHARMA PLCsponsored ads | $51,954,865 | -22.9% | 3,187,415 | 0.0% | 2.00% | -35.7% | |
| New | APOGEE THERAPEUTICS INC | $51,426,145 | – | 2,414,373 | +100.0% | 1.98% | – | |
| PACB | Buy | PACIFIC BIOSCIENCES CALIF IN | $50,100,000 | +159.6% | 6,000,000 | +313.5% | 1.93% | +116.6% |
| VRDN | Buy | VIRIDIAN THERAPEUTICS INC | $45,456,516 | +49.3% | 2,963,267 | +131.6% | 1.76% | +24.6% |
| NVCR | New | NOVOCURE LTD | $40,375,000 | – | 2,500,000 | +100.0% | 1.56% | – |
| New | HILLEVAX INC | $39,005,000 | – | 2,900,000 | +100.0% | 1.51% | – | |
| RPTX | Buy | REPARE THERAPEUTICS INC | $37,058,190 | +28.4% | 3,067,731 | +12.5% | 1.43% | +7.0% |
| AGEN | Buy | AGENUS INC | $35,818,219 | -25.4% | 31,697,539 | +5.7% | 1.38% | -37.8% |
| FDMT | 4D MOLECULAR THERAPEUTICS IN | $35,365,302 | -29.6% | 2,778,107 | 0.0% | 1.36% | -41.3% | |
| AUTL | AUTOLUS THERAPEUTICS PLCspon ads | $34,950,000 | -2.1% | 15,000,000 | 0.0% | 1.35% | -18.4% | |
| NBIX | New | NEUROCRINE BIOSCIENCES INC | $33,750,000 | – | 300,000 | +100.0% | 1.30% | – |
| TERN | Buy | TERNS PHARMACEUTICALS INC | $30,180,000 | +213.8% | 6,000,000 | +445.9% | 1.16% | +161.8% |
| RAPT | Buy | RAPT THERAPEUTICS INC | $24,930,000 | +32.7% | 1,500,000 | +49.3% | 0.96% | +10.6% |
| BEAM | Sell | BEAM THERAPEUTICS INC | $24,426,166 | -41.9% | 1,015,641 | -22.9% | 0.94% | -51.6% |
| ANAB | New | ANAPTYSBIO INC | $24,170,801 | – | 1,345,813 | +100.0% | 0.93% | – |
| OLMA | New | OLEMA PHARMACEUTICALS INC | $23,846,541 | – | 1,930,894 | +100.0% | 0.92% | – |
| NRIX | NURIX THERAPEUTICS INC | $23,562,944 | -21.3% | 2,997,830 | 0.0% | 0.91% | -34.4% | |
| ANIP | Sell | ANI PHARMACEUTICALS INC | $23,224,000 | -16.1% | 400,000 | -22.2% | 0.90% | -30.1% |
| New | AMYLYX PHARMACEUTICALS INC | $23,058,424 | – | 1,259,335 | +100.0% | 0.89% | – | |
| BNTX | New | BIONTECH SEsponsored ads | $21,728,000 | – | 200,000 | +100.0% | 0.84% | – |
| DYN | Sell | DYNE THERAPEUTICS INC | $21,536,901 | -23.4% | 2,403,672 | -3.8% | 0.83% | -36.2% |
| MRNA | New | MODERNA INC | $20,658,000 | – | 200,000 | +100.0% | 0.80% | – |
| SLN | SILENCE THERAPEUTICS PLCads | $19,164,516 | +78.5% | 1,951,580 | 0.0% | 0.74% | +48.9% | |
| PNT | POINT BIOPHARMA GLOBAL INC | $18,553,039 | -26.4% | 2,781,565 | 0.0% | 0.72% | -38.6% | |
| ZURA BIO LTD | $16,651,800 | -19.5% | 2,523,000 | 0.0% | 0.64% | -32.9% | ||
| New | ORCHARD THERAPEUTICS PLCspon ads new | $15,782,109 | – | 2,041,670 | +100.0% | 0.61% | – | |
| EWTX | EDGEWISE THERAPEUTICS INC | $15,757,500 | -26.1% | 2,750,000 | 0.0% | 0.61% | -38.4% | |
| PRTA | PROTHENA CORP PLCput | $12,062,500 | -29.3% | 250,000 | 0.0% | 0.47% | -41.0% | |
| NKTR | Buy | NEKTAR THERAPEUTICS | $10,959,040 | +6.0% | 18,400,000 | +2.4% | 0.42% | -11.7% |
| MORF | Buy | MORPHIC HLDG INC | $10,782,523 | -13.2% | 470,647 | +117.1% | 0.42% | -27.7% |
| ABOS | Sell | ACUMEN PHARMACEUTICALS INC | $10,429,133 | -44.6% | 2,513,044 | -35.8% | 0.40% | -53.8% |
| AGIO | New | AGIOS PHARMACEUTICALS INC | $10,450,613 | – | 422,247 | +100.0% | 0.40% | – |
| NUVB | NUVATION BIO INC | $10,345,722 | -25.6% | 7,720,688 | 0.0% | 0.40% | -37.9% | |
| Sell | VIGIL NEUROSCIENCE INC | $9,524,836 | -42.9% | 1,767,131 | -0.4% | 0.37% | -52.3% | |
| RLMD | RELMADA THERAPEUTICS INC | $8,513,454 | +22.0% | 2,837,818 | 0.0% | 0.33% | +1.9% | |
| Sell | ASTRIA THERAPEUTICS INC | $7,742,533 | -45.2% | 1,037,873 | -38.9% | 0.30% | -54.4% | |
| TXG | New | 10X GENOMICS INC | $7,536,004 | – | 182,691 | +100.0% | 0.29% | – |
| NVAX | New | NOVAVAX INC | $7,240,000 | – | 1,000,000 | +100.0% | 0.28% | – |
| New | ACELYRIN INC | $5,606,609 | – | 551,289 | +100.0% | 0.22% | – | |
| GHRS | GH RESEARCH PLCordinary shares | $5,018,970 | -15.3% | 499,400 | 0.0% | 0.19% | -29.2% | |
| New | SYROS PHARMACEUTICALS INC | $3,272,516 | – | 828,485 | +100.0% | 0.13% | – | |
| SRRK | New | SCHOLAR ROCK HLDG CORP | $2,512,371 | – | 353,855 | +100.0% | 0.10% | – |
| CMPS | Sell | COMPASS PATHWAYS PLCsponsored ads | $2,430,338 | -56.7% | 328,424 | -51.6% | 0.09% | -63.8% |
| HRTX | HERON THERAPEUTICS INC | $2,149,305 | -11.2% | 2,086,704 | 0.0% | 0.08% | -25.9% | |
| ETNB | Sell | 89BIO INC | $1,406,244 | -85.2% | 91,078 | -81.9% | 0.05% | -87.8% |
| IPSC | Sell | CENTURY THERAPEUTICS INC | $1,086,016 | -66.4% | 543,008 | -46.9% | 0.04% | -72.0% |
| Exit | MINK THERAPEUTICS INC | $0 | – | -324,867 | -100.0% | -0.03% | – | |
| IMUX | Exit | IMMUNIC INC | $0 | – | -308,314 | -100.0% | -0.04% | – |
| ALLK | Exit | ALLAKOS INC | $0 | – | -228,277 | -100.0% | -0.05% | – |
| FGEN | Exit | FIBROGEN INCcall | $0 | – | -764,700 | -100.0% | -0.10% | – |
| Exit | MOONLAKE IMMUNOTHERAPEUTICSclass a ord | $0 | – | -108,450 | -100.0% | -0.26% | – | |
| ZNTL | Exit | ZENTALIS PHARMACEUTICALS INC | $0 | – | -300,300 | -100.0% | -0.39% | – |
| INZY | Exit | INOZYME PHARMA INC | $0 | – | -1,644,021 | -100.0% | -0.42% | – |
| ORTX | Exit | ORCHARD THERAPEUTICS PLCspon ads new | $0 | – | -2,041,670 | -100.0% | -0.49% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2023-11-14
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| JAZZ PHARMACEUTICALS PLC | 8 | Q3 2023 | 7.2% |
| TRAVERE THERAPEUTICS INC | 8 | Q3 2023 | 5.7% |
| IMMUNOVANT INC | 8 | Q3 2023 | 7.2% |
| BICYCLE THERAPEUTICS PLC | 8 | Q3 2023 | 5.2% |
| BEAM THERAPEUTICS INC | 8 | Q3 2023 | 3.9% |
| 4D MOLECULAR THERAPEUTICS IN | 8 | Q3 2023 | 2.9% |
| REPARE THERAPEUTICS INC | 8 | Q3 2023 | 3.1% |
| VIRIDIAN THERAPEUTICS INC | 8 | Q3 2023 | 2.2% |
| DYNE THERAPEUTICS INC | 8 | Q3 2023 | 2.2% |
| SILENCE THERAPEUTICS PLC | 8 | Q3 2023 | 1.6% |
View Deep Track Capital, LP's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| Orchard Therapeutics plc | March 20, 2023 | 19,125,150 | 10.0% |
| ARDELYX, INC.Sold out | February 14, 2023 | 0 | 0.0% |
| ASSEMBLY BIOSCIENCES, INC. | February 14, 2023 | 1,833,437 | 3.8% |
| Aurinia Pharmaceuticals Inc. | February 14, 2023 | 324,238 | 0.2% |
| CHINOOK THERAPEUTICS, INC. | February 14, 2023 | 3,000,000 | 4.7% |
| Forma Therapeutics Holdings, Inc.Sold out | February 14, 2023 | 0 | 0.0% |
| Global Blood Therapeutics, Inc.Sold out | February 14, 2023 | 0 | 0.0% |
| HOOKIPA Pharma Inc. | February 14, 2023 | 1,240,369 | 2.4% |
| KalVista Pharmaceuticals, Inc.Sold out | February 14, 2023 | 0 | 0.0% |
| Keros Therapeutics, Inc.Sold out | February 14, 2023 | 0 | 0.0% |
View Deep Track Capital, LP's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| SC 13G | 2024-04-12 |
| SC 13G | 2024-04-05 |
| SC 13G | 2024-03-22 |
| SC 13G | 2024-03-22 |
| SC 13G | 2024-03-22 |
| SC 13G | 2024-03-15 |
| 3 | 2024-03-14 |
| SC 13G | 2024-03-08 |
| SC 13G | 2024-02-23 |
| 13F-HR | 2024-02-14 |
View Deep Track Capital, LP's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.